We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Follow-Up Study Investigates Progression of Vascular Plaque

By HospiMedica International staff writers
Posted on 28 Jun 2017
A new large-scale study in the US that will investigate the progression of vascular atherosclerotic plaque in patients from a larger, previous study is slated to begin.

The new study will look at disease progression in at least 1,000 patients from a previous study that recruited 7,687 participants between the years 2008 and 2009. More...
Researchers in the previous study used a novel ultrasound imaging method to identify atherosclerotic plaque disease in carotid arteries, and studied how this could affect the risk of the participants developing a heart attack or stroke.

The start of the new BioImage-2 study in Florida and Illinois was announced by the Mount Sinai Hospital (ISMMS; New York, NK, USA) and BioImage-2 (Lexington, MA, USA). The study will begin in September 2017 and continue for one year. The study is intended to promote research into carotid ultrasound imaging methods that can help clinicians decide how best to prevent heart attacks and strokes. The new study is intended to develop and test tools for bringing such imaging techniques into routine clinical practice and provide tailored preventive therapies.

Principal investigator of the BioImage-2 study, Director of Mount Sinai Heart, and Physician-in-Chief, Valentin Fuster, MD, said "Today a broad range of options exist for prevention of atherosclerotic vessel disease, which may lead to heart attack and stroke. If we can identify and characterize subclinical disease early and monitor this over the years, this may one day help us to better identify those who stand to gain most from the intensive preventive therapy options now available."


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Multi-Chamber Washer-Disinfector
WD 390
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.